Advocacy News

advocacy

Statement of Lymphoma Research Foundation on Access to Treatment

Policymakers in Washington, DC, and state capitols are considering measures to address the cost of health care, including prescription drugs, and to address insurance adequacy issues. As debate on these initiatives intensifies, we urge that policymakers consider the needs of people with lymphoma and lymphoma survivors.

LRF Urges CDC to Prioritize Blood Cancer Patients for COVID-19 Vaccine

LRF Urges CDC to Prioritize Blood Cancer Patients for COVID-19 Vaccine VISIT THE COVID-19 LEARNING CENTER FOR…

Why the U.S. Needs Non-Profits Now More Than Ever

By Michael Werner and Christina Kazhe The COVID-19 pandemic has brought the country to a…

LRF Advocates for Patient Access to Cellular Therapies

On November 2, 2019, the Lymphoma Research Foundation sent a letter to Donald Thompson, Director, Division of Acute Care at the Centers for Medicare and Medicaid Services requesting for MS-DRG reclassification for certain cases involving the use of chimeric antigen receptor T-cell (CAR T-cell) therapies.

Day of Action: Urge Congress to Support the Clinical Treatment Act

On July 10, the Lymphoma Research Foundation (LRF) is participating in a day of action…

Congress to Consider Federal Cancer Research Budget

Every year the National Institutes of Health (NIH) and National Cancer Institute (NCI) are required…

LRF Releases Monograph Addressing Early Career Scientist Crisis

In the face of declining federal and institutional resources, the Lymphoma Research Foundation’s (LRF) commitment…

Foundation Releases 2019 Public Policy Agenda Outlining Policy Priorities For Year Ahead

The Lymphoma Research Foundation (LRF) is proud to be a national thought leader in the…

Foundation Hosts Biden Cancer Community Summit to Address Funding for Early Career Researchers

As part of the Lymphoma Research Foundation’s ongoing efforts in support of early career lymphoma…

Buildings and Landmarks Worldwide Join LRF to Light It Red for Blood Cancer Awareness Month

Since 2011, the Lymphoma Research Foundation (LRF) has been a pioneer in shedding a “light”…